Cargando…

Phosphatidylinositol-3,4,5-Trisphosphate Dependent Rac Exchange Factor 1 (PREX1) is a Novel Predictor of Prognosis for Breast Cancer Patients: A Retrospective Case Series

BACKGROUND: In previous studies, higher expression of PREX1 (PtdIns (3,4,5)P3-dependent Rac exchanger 1) has been detected in some subsets of breast cancer, and activation of PREX1 has been associated with tumor progression in vivo. However, an association between PREX1 and breast cancer prognosis h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Ying, Zhang, Jing, Zhou, Yidong, Mao, Feng, Lin, Yan, Xu, Yali, Guan, Jinghong, Shen, Songjie, Pan, Bo, Wang, Changjun, Peng, Li, Huang, Xin, Li, Yan, Cao, Xi, Sun, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2019
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738004/ https://www.ncbi.nlm.nih.gov/pubmed/31473760 http://dx.doi.org/10.12659/MSM.915845

Ejemplares similares

Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 is a diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Cai, Yi, et al.
Publicado: (2020)

Feedback regulation between phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 and transforming growth factor β1 and prognostic value in gastric cancer
por: Shao, Qi, et al.
Publicado: (2020)

Nuclear Phosphatidylinositol 3,4,5-Trisphosphate Interactome Uncovers an Enrichment in Nucleolar Proteins
por: Mazloumi Gavgani, Fatemeh, et al.
Publicado: (2021)

Gliotoxin Suppresses Macrophage Immune Function by Subverting Phosphatidylinositol 3,4,5-Trisphosphate Homeostasis
por: Schlam, Daniel, et al.
Publicado: (2016)

Phosphatidylinositol 3,4,5-trisphosphate Localization in Recycling Endosomes Is Necessary for AP-1B–dependent Sorting in Polarized Epithelial Cells
por: Fields, Ian C., et al.
Publicado: (2010)

Nodal signaling regulates endodermal cell motility and actin dynamics via Rac1 and Prex1
por: Woo, Stephanie, et al.
Publicado: (2012)

Defining the Functional Domain of Programmed Cell Death 10 through Its Interactions with Phosphatidylinositol-3,4,5-Trisphosphate
por: Dibble, Christopher F., et al.
Publicado: (2010)

Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson’s disease-related fibril polymorphism
por: Choong, Chi-Jing, et al.
Publicado: (2023)

New drug-like small molecule antagonizes phosphatidylinositol (3,4,5)-trisphosphate (PIP3) in patients with conotruncal heart defects
por: Fayez, Alaaeldin G., et al.
Publicado: (2023)

Silencing Rac1 and Prex1 Inhibit Epithelial–Mesenchymal Transition in Human Gastric Cancer Cells Induced by Transforming Growth Factor-β1
por: Gao, Xinyan, et al.
Publicado: (2023)

Synthesis and Cellular Labeling of Multifunctional Phosphatidylinositol Bis‐ and Trisphosphate Derivatives
por: Müller, Rainer, et al.
Publicado: (2021)

The Phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P(3)) Binder Rasa3 Regulates Phosphoinositide 3-kinase (PI3K)-dependent Integrin α(IIb)β(3) Outside-in Signaling
por: Battram, Anthony M., et al.
Publicado: (2017)

Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse
por: Zhong, Ying, et al.
Publicado: (2013)

PREX1 drives spontaneous bone dissemination of ER+ breast cancer cells
por: Clements, Miranda E., et al.
Publicado: (2019)

Somatic mutations of PREX2 gene in patients with hepatocellular carcinoma
por: Yang, Ming-Hui, et al.
Publicado: (2019)

NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells
por: Zhong, Ying, et al.
Publicado: (2016)

Melanoma genome sequencing reveals frequent PREX2 mutations
por: Berger, Michael F., et al.
Publicado: (2012)

Omitting radiotherapy is safe in breast cancer patients ≥ 70 years old after breast-conserving surgery without axillary lymph node operation
por: Zhong, Ying, et al.
Publicado: (2020)

Knockdown of PREX2a inhibits the malignant phenotype of glioma cells
por: Liu, Liang, et al.
Publicado: (2021)

Knockdown of PREX2a inhibits the malignant phenotype of osteosarcoma cells
por: Dai, Zixun, et al.
Publicado: (2022)

A novel phosphatidylinositol(3,4,5)P(3) pathway in fission yeast
por: Mitra, Prasenjit, et al.
Publicado: (2004)

Syntaxin4 Interacting Protein (Synip) Binds Phosphatidylinositol (3,4,5) Triphosphate
por: Saito, Tsugumichi, et al.
Publicado: (2012)

Beta 2 integrin engagement triggers actin polymerization and phosphatidylinositol trisphosphate formation in non-adherent human neutrophils
Publicado: (1993)

Registered report: Melanoma genome sequencing reveals frequent PREX2 mutations
por: Chroscinski, Denise, et al.
Publicado: (2014)

Replication Study: Melanoma genome sequencing reveals frequent PREX2 mutations
por: Horrigan, Stephen K, et al.
Publicado: (2017)

Predictors of nonsentinel lymph node metastasis in patients with breast cancer with metastasis in the sentinel node
por: Zhou, Yidong, et al.
Publicado: (2019)

PREX1 integrates G protein-coupled receptor and phosphoinositide 3-kinase signaling to promote glioblastoma invasion
por: Gont, Alexander, et al.
Publicado: (2016)

Selective determinants of inositol 1,4,5-trisphosphate and adenophostin A interactions with type 1 inositol 1,4,5-trisphosphate receptors
por: Rossi, Ana M, et al.
Publicado: (2010)

Localization and projected role of phosphatidylinositol 4-kinases IIα and IIβ in inositol 1,4,5-trisphosphate-sensitive nucleoplasmic Ca(2+) store vesicles
por: Yoo, Seung Hyun, et al.
Publicado: (2014)

Temporal profiling of changes in phosphatidylinositol 4,5-bisphosphate, inositol 1,4,5-trisphosphate and diacylglycerol allows comprehensive analysis of phospholipase C-initiated signalling in single neurons(1)
por: Nelson, Carl P, et al.
Publicado: (2008)

Inositol 1,4,5-Trisphosphate Receptors in Hypertension
por: Eid, Ali H., et al.
Publicado: (2018)

Concurrent administration of trastuzumab and anthracyclines as adjuvant regimen for HER2-positive breast cancer: a randomised controlled trial
por: Shen, Songjie, et al.
Publicado: (2017)

GnRHa for Ovarian Protection and the Association between AMH and Ovarian Function during Adjuvant Chemotherapy for Breast Cancer
por: Zhong, Ying, et al.
Publicado: (2019)

Differential Rac1 signalling by guanine nucleotide exchange factors implicates FLII in regulating Rac1-driven cell migration
por: Marei, Hadir, et al.
Publicado: (2016)

The influence on survival of delay in the treatment initiation of screening detected non-symptomatic breast cancer
por: Li, Yan, et al.
Publicado: (2019)

Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: study protocol of a randomized controlled trial
por: Wang, Changjun, et al.
Publicado: (2020)

PREX2 promotes the proliferation, invasion and migration of pancreatic cancer cells by modulating the PI3K signaling pathway
por: Yang, Jianyi, et al.
Publicado: (2021)

Targeting and activation of Rac1 are mediated by the exchange factor β-Pix
por: ten Klooster, Jean Paul, et al.
Publicado: (2006)

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

Would 1.0 cm be a more suitable cutoff to subdivide pT1 tumors in hormone receptor‐negative and HER2‐positive breast cancer?
por: Wang, Changjun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bdibjrngrs8ef5v3bej931l44c